SUBSCRIBE
3 minutes
University of Edinburgh spin-out Kynos Therapeutics has secured a £9 million investment package led by Epidarex Capital, joined by IP Group and Scottish Enterprise. Kynos has also been awarded £2.5m through an Innovate UK grant to fund a first-time in human Phase 1 clinical trial of its
